Intravitreal bevacizumab for subfoveal choroidal neovascularization associated with pattern dystrophy

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 9, 2010, Pages 4358-4361

  Parodi, Maurizio Battaglia ^a   Iacono, Pierluigi ^b   Cascavilla, Marialucia ^a   Zucchiatti, Ilaria ^a   Kontadakis, Dimitrios Stylianos ^a   Bandello, Francesco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CORNEA THICKNESS; DISEASE ASSOCIATION; DISEASE CONTROL; DRUG EFFICACY; FEMALE; HUMAN; LOADING DRUG DOSE; MALE; OPEN STUDY; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETINA DYSTROPHY; RETINA FOVEA; SUBRETINAL NEOVASCULARIZATION; TREATMENT RESPONSE; VISUAL ACUITY; VISUAL IMPAIRMENT; DRUG EFFECT; FOLLOW UP; INTRAOCULAR DRUG ADMINISTRATION; MIDDLE AGED; PATHOLOGY; TREATMENT OUTCOME; VASCULARIZATION; VITREOUS BODY;

ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; FOLLOW-UP STUDIES; FOVEA CENTRALIS; HUMANS; INJECTIONS, INTRAOCULAR; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RETINAL PIGMENT EPITHELIUM; TREATMENT OUTCOME; VISUAL ACUITY; VITREOUS BODY;

EID: 77957354664     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5237     Document Type: Article

References (10)

1. Gass JDM. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment. 4th ed. St. Louis: CV Mosby; 1997;314-325.
2. Parodi MB. Eredodistrofie Corioretiniche. Rome: Verduci Editore; 2002:21-60.
3. Taillanter-Francoz N, Remy C, Bonnet M, Baserer T. Choroidal neovessels associated with reticular dystrophy of the pigment epithelium: case report (in French). Bull Soc Ophtalmol Fr. 1981; 81:539-541.
4. Marano F, Deutman AF, Pinckers AJ, et al. Reticular dystrophy of the retinal pigment epithelium and choroidal neovascularization: a fluorescein and ICGV study. Acta Ophthalmol Scand. 1997;75: 22-27.
5. Marano F, Deutman AF, Leys A, Aandekerk AL. Hereditary retinal dystrophies and choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol. 2000;238:760-764.
6. Parodi MB, Da Pozzo S, Ravalico G. Photodynamic therapy for choroidal neovascularization associated with pattern dystrophy. Retina. 2003;23:171-176.
7. Parodi MB, Liberali T, Pedio M, et al. Photodynamic therapy of subfoveal choroidal neovascularization secondary to reticular pattern dystrophy: three-year results of an uncontrolled, prospective case series. Am J Ophthalmol. 2006;141:1152-1154.
8. Parodi MB. Choroidal neovascularization in fundus pulverulentus. Acta Ophthalmol Scand. 2002;80:559-560.
9. Montero JA, Ruiz-Moreno JM, De La Vega C. Intravitreal bevacizumab for adult-onset vitelliform dystrophy: a case report. Eur J Ophthalmol. 2007;17:983-986.
10. Schutt F, Davies S, Kopitz J, et al. Photodamage to human RPE cells by A2-E, a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci. 2000;41:2303-2308.